Cytokinetics, Incorporated

Overview

Cytokinetics, Incorporated is a biopharmaceutical company focused on the discovery and development of first-in-class muscle activators and inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. The company's lead drug candidates are aimed at treating conditions such as heart failure and amyotrophic lateral sclerosis (ALS).

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Cytokinetics, Incorporated in our records. PharmaTek screens the full directory against live FDA enforcement data.